Anna-Karin Hamberg

Patient Median-Based Quality Control in Lamotrigine Therapeutic Drug Monitoring: A 15-Year Retrospective Study

Larsson, Anders; Eriksson, Mats B.; Steinholtz, Linda; Hamberg, Anna-Karin

Ingår i Pharmaceutics, 2026

• DOI för Patient Median-Based Quality Control in Lamotrigine Therapeutic Drug Monitoring: A 15-Year Retrospective Study
• Ladda ner fulltext (pdf) av Patient Median-Based Quality Control in Lamotrigine Therapeutic Drug Monitoring: A 15-Year Retrospective Study

Decreasing Tacrolimus Concentrations in Routine Therapeutic Drug Monitoring Data Indicate Adherence to Updated Therapeutic Goals

Larsson, Anders; Saldeen, Johan; Cedernaes, Jonathan; Eriksson, Mats et al.

Ingår i Biomedicines, s. 94-94, 2026

• DOI för Decreasing Tacrolimus Concentrations in Routine Therapeutic Drug Monitoring Data Indicate Adherence to Updated Therapeutic Goals
• Ladda ner fulltext (pdf) av Decreasing Tacrolimus Concentrations in Routine Therapeutic Drug Monitoring Data Indicate Adherence to Updated Therapeutic Goals

Long term monitoring of serum valproate assays using patient median values show stable test results over a period of more than 20 years

Larsson, Anders; Hamberg, Anna-Karin; Cedernaes, Jonathan; Karlsson, Mathias

Ingår i Pharmacological Research - Reports, 2025

• DOI för Long term monitoring of serum valproate assays using patient median values show stable test results over a period of more than 20 years
• Ladda ner fulltext (pdf) av Long term monitoring of serum valproate assays using patient median values show stable test results over a period of more than 20 years

New Monitoring Recommendations for Digoxin During the Last Decade Are Associated With Decreased Serum Digoxin Concentrations in Patient Samples

Larsson, Anders; Hamberg, Anna-Karin; Cedernaes, Jonathan; Hallberg, Pär et al.

Ingår i Basic & Clinical Pharmacology & Toxicology, 2025

• DOI för New Monitoring Recommendations for Digoxin During the Last Decade Are Associated With Decreased Serum Digoxin Concentrations in Patient Samples
• Ladda ner fulltext (pdf) av New Monitoring Recommendations for Digoxin During the Last Decade Are Associated With Decreased Serum Digoxin Concentrations in Patient Samples

Model-informed precision dosing of vancomycin in clinical practice: an intervention development study

Swartling, Maria; Hamberg, Anna-Karin; Furebring, Mia; Tängdén, Thomas et al.

Ingår i International Journal of Clinical Pharmacy, s. 178-186, 2025

• DOI för Model-informed precision dosing of vancomycin in clinical practice: an intervention development study
• Ladda ner fulltext (pdf) av Model-informed precision dosing of vancomycin in clinical practice: an intervention development study

Patient Median-Based Quality Control in Lamotrigine Therapeutic Drug Monitoring: A 15-Year Retrospective Study

Larsson, Anders; Eriksson, Mats B.; Steinholtz, Linda; Hamberg, Anna-Karin

Ingår i Pharmaceutics, 2026

• DOI för Patient Median-Based Quality Control in Lamotrigine Therapeutic Drug Monitoring: A 15-Year Retrospective Study
• Ladda ner fulltext (pdf) av Patient Median-Based Quality Control in Lamotrigine Therapeutic Drug Monitoring: A 15-Year Retrospective Study

Decreasing Tacrolimus Concentrations in Routine Therapeutic Drug Monitoring Data Indicate Adherence to Updated Therapeutic Goals

Larsson, Anders; Saldeen, Johan; Cedernaes, Jonathan; Eriksson, Mats et al.

Ingår i Biomedicines, s. 94-94, 2026

• DOI för Decreasing Tacrolimus Concentrations in Routine Therapeutic Drug Monitoring Data Indicate Adherence to Updated Therapeutic Goals
• Ladda ner fulltext (pdf) av Decreasing Tacrolimus Concentrations in Routine Therapeutic Drug Monitoring Data Indicate Adherence to Updated Therapeutic Goals

Long term monitoring of serum valproate assays using patient median values show stable test results over a period of more than 20 years

Larsson, Anders; Hamberg, Anna-Karin; Cedernaes, Jonathan; Karlsson, Mathias

Ingår i Pharmacological Research - Reports, 2025

• DOI för Long term monitoring of serum valproate assays using patient median values show stable test results over a period of more than 20 years
• Ladda ner fulltext (pdf) av Long term monitoring of serum valproate assays using patient median values show stable test results over a period of more than 20 years

New Monitoring Recommendations for Digoxin During the Last Decade Are Associated With Decreased Serum Digoxin Concentrations in Patient Samples

Larsson, Anders; Hamberg, Anna-Karin; Cedernaes, Jonathan; Hallberg, Pär et al.

Ingår i Basic & Clinical Pharmacology & Toxicology, 2025

• DOI för New Monitoring Recommendations for Digoxin During the Last Decade Are Associated With Decreased Serum Digoxin Concentrations in Patient Samples
• Ladda ner fulltext (pdf) av New Monitoring Recommendations for Digoxin During the Last Decade Are Associated With Decreased Serum Digoxin Concentrations in Patient Samples

Model-informed precision dosing of vancomycin in clinical practice: an intervention development study

Swartling, Maria; Hamberg, Anna-Karin; Furebring, Mia; Tängdén, Thomas et al.

Ingår i International Journal of Clinical Pharmacy, s. 178-186, 2025

• DOI för Model-informed precision dosing of vancomycin in clinical practice: an intervention development study
• Ladda ner fulltext (pdf) av Model-informed precision dosing of vancomycin in clinical practice: an intervention development study

Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events

Attelind, Sofia; Hallberg, Pär; Wadelius, Mia; Hamberg, Anna-Karin et al.

Ingår i Frontiers in Genetics, 2022

• DOI för Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
• Ladda ner fulltext (pdf) av Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events

Effect of CYP2C9, VKORC1, and CYP4F2 on warfarin maintenance dose in children aged less than 18 year of age: systematic review and meta-analysis

Takeuchi, M.; Kobayashi, T.; Biss, T.; Kamali, F. et al.

Ingår i Clinical Pharmacology and Therapeutics, 2018

• DOI för Effect of CYP2C9, VKORC1, and CYP4F2 on warfarin maintenance dose in children aged less than 18 year of age: systematic review and meta-analysis

Is Trough Concentration of Vancomycin Predictive of the Area Under the Curve?: A Commentary

Hamberg, Anna-Karin; Keizer, Ron

Ingår i Therapeutic Drug Monitoring, s. 303-303, 2017

• DOI för Is Trough Concentration of Vancomycin Predictive of the Area Under the Curve?: A Commentary

A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children

Hamberg, Anna-Karin; Hellman, Jacob; Dahlberg, Jonny; Jonsson, E Niclas et al.

Ingår i BMC Medical Informatics and Decision Making, 2015

• DOI för A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children
• Ladda ner fulltext (pdf) av A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children

Characterising variability in warfarin dose requirements in children using modelling and simulation

Hamberg, Anna-Karin; Wadelius, Mia; Friberg, Lena E; Biss, Tina T et al.

Ingår i British Journal of Clinical Pharmacology, s. 158-169, 2013

• DOI för Characterising variability in warfarin dose requirements in children using modelling and simulation

Warfarin dose prediction in children using pharmacometric bridging: comparison with published pharmacogenetic dosing algorithms

Hamberg, Anna-Karin; Friberg, Lena E; Hanséus, Katarina; Ekman-Joelsson, Britt-Marie et al.

Ingår i European Journal of Clinical Pharmacology, s. 1275-1283, 2013

• DOI för Warfarin dose prediction in children using pharmacometric bridging: comparison with published pharmacogenetic dosing algorithms
• Ladda ner fulltext (pdf) av Warfarin dose prediction in children using pharmacometric bridging: comparison with published pharmacogenetic dosing algorithms

Warfarin dose prediction in children using pharmacogenetics information

Biss, Tina; Hamberg, Anna-Karin; Avery, Peter; Wadelius, Mia et al.

Ingår i British Journal of Haematology, s. 106-109, 2012

• DOI för Warfarin dose prediction in children using pharmacogenetics information

A Proposal for an Individualized Pharmacogenetics-Based Warfarin Initiation Dose Regimen for Patients Commencing Anticoagulation Therapy

Avery, P. J.; Jorgensen, A.; Hamberg, Anna-Karin; Wadelius, Mia et al.

Ingår i Clinical Pharmacology and Therapeutics, s. 701-706, 2011

• DOI för A Proposal for an Individualized Pharmacogenetics-Based Warfarin Initiation Dose Regimen for Patients Commencing Anticoagulation Therapy

A Pharmacometric Model Describing the Relationship Between Warfarin Dose and INR Response With Respect to Variations in CYP2C9, VKORC1, and Age

Hamberg, Anna-Karin; Wadelius, Mia; Lindh, J. D.; Dahl, Marja- Liisa et al.

Ingår i Clinical Pharmacology and Therapeutics, s. 727-734, 2010

• DOI för A Pharmacometric Model Describing the Relationship Between Warfarin Dose and INR Response With Respect to Variations in CYP2C9, VKORC1, and Age

Predicting the relative importance of genetic, clinical and demographic factors on warfarin dose in children using pharmacometric modelling

Hamberg, Anna-Karin; Wadelius, Mia; Friberg, Lena E; Biss, Tina T et al.

General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children

Bouazza, Naim; Dokoumetzidis, Aristides; Knibbe, Catherijne A. J.; de Wildt, Saskia N. et al.

Ingår i British Journal of Clinical Pharmacology, s. 4985-4996, 2022

• DOI för General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children

CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis

Takeuchi, Masanobu; Kobayashi, Tohru; Biss, Tina; Kamali, Farhad et al.

Ingår i The Pharmacogenomics Journal, s. 306-319, 2020

• DOI för CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis

Pharmacogenetics-based warfarin dosing in children

Hamberg, Anna-Karin; Wadelius, Mia

Ingår i Pharmacogenomics (London), s. 361-374, 2014

• DOI för Pharmacogenetics-based warfarin dosing in children

Pharmacometric Models for Individualisation of Warfarin in Adults and Children

Hamberg, Anna-Karin

2013

• Ladda ner fulltext (pdf) av Pharmacometric Models for Individualisation of Warfarin in Adults and Children